The cellular basis of septic shock

Critical Care Nursing Clinics of North America

Volumn 15, Issue 1, 2003, Pages 13-25

  Sommers, Marilyn Sawyer ^a  

^a UNIVERSITY OF CINCINNATI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; AMIKACIN; AMPICILLIN; ARACHIDONIC ACID DERIVATIVE; BETA INTERFERON; BETA LACTAM ANTIBIOTIC; BRADYKININ; C REACTIVE PROTEIN; CEFACLOR; CEFOTAXIME; CEFOTETAN; CEFOXITIN; CEFTAZIDIME; CEPHALOSPORIN; CLAVULANIC ACID; CLINDAMYCIN; CLOMIFENE; GAMMA INTERFERON; GENTAMICIN; HISTAMINE; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 8; LEUKOTRIENE DERIVATIVE; METRONIDAZOLE; MONOCYTE CHEMOTACTIC PROTEIN 1; NAFCILLIN; NITRIC OXIDE; PENICILLINASE; PIPERACILLIN; PROSTAGLANDIN DERIVATIVE; SULBACTAM; SULTAMICILLIN; TAZOBACTAM; THROMBOCYTE ACTIVATING FACTOR; THROMBOXANE A2; TICARCILLIN; TIMENTIN; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG; ANTIINFECTIVE AGENT; AUTACOID; CYTOKINE;

BACTERIAL INFECTION; CARDIOVASCULAR RISK; CELL ACTIVITY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DISEASE SEVERITY; DRUG ACTIVITY; ENDOTHELIUM CELL; ENZYME ACTIVITY; FIBRINOLYSIS; HEMODYNAMICS; HUMAN; IMMUNE RESPONSE; IMMUNOREACTIVITY; INCIDENCE; INFECTION PREVENTION; MOLECULAR MECHANICS; MORTALITY; MULTIPLE ORGAN FAILURE; NURSING; PATHOPHYSIOLOGY; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; REVIEW; SEPSIS; SEPTIC SHOCK; SEQUENCE ANALYSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; THROMBOCYTE COUNT; CLASSIFICATION; IMMUNOLOGY; INFLAMMATION; METABOLISM; NOMENCLATURE;

ANTI-BACTERIAL AGENTS; CYTOKINES; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; SHOCK, SEPTIC; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TERMINOLOGY;

EID: 0037364634     PISSN: 08995885     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0899-5885(02)00046-1     Document Type: Review

References (33)

1. Angus D.C., Linde-Zwirble W.T., Lidicker J., et al. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med. 29:2001;1303-1310
2. Glauser M.P. Pathophysiologic basis of sepsis: considerations for future strategies of intervention. Crit Care Med. 28:2000;S4-S8
3. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference. Definitions for sepsis and multiple organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med. 20:1992;864-874
4. Bone R.C., Grodzin C.J., Balk R.A. Sepsis: a new hypothesis for pathogenesis of the disease process. Chest. 112:1997;235-243
5. Minino A.M., Smith B.L. Deaths: preliminary data for 2000. Natl Vital Stat Rep. 49:2001;1-40
6. Angus D., Wax R. Epidemiology of sepsis: an update. Crit Care Med. 29:(Suppl):2001;S109-S116
7. Friedman G., Silva E., Vincent J.L. Has the mortality of septic shock changed with time. Crit Care Med. 26:1998;2078-2086
8. Vincent J.L., DeBacker D. Pathophysiology of septic shock. Advances in Sepsis. 1:2001;87-92
9. Corwin E.J. Understanding cytokines. I. Physiology and mechanism of action. Biol Res Nurs. 2:2000;30-40
10. Corwin E.J. Understanding cytokines. II. Implications for nursing research and practice. Biol Res Nurs. 2:2000;31-48
11. Venes D. Taber's cyclopedic medical dictionary. 19th edition:2001;FA Davis, Philadelphia
12. Aird W.C. Endothelial cell dynamics and complexity theory. Crit Care Med. 30:(Suppl):2002;S180-S185
13. Gibot S., Cariou A., Drouet L., Rossignol M., Ripoll L. Association between a genomic polymorphism within the CD14 locus and septic shock susceptibility and mortality rate. Crit Care Med. 30:2002;969-973
14. Randolph A.G. Mining for the genetic determinants of septic shock: when is it really gold? Crit Care Med. 30:2002;1161-1162
15. Goldsby R.A., Kindt T.J., Osborne B.A. Kuby immunology. 2002;WH Freeman, New York
16. Pettila V., Pentti J., Pettila M., Takkunen O., Jousela I. Predictive value of antithrombin III and serum C-reactive protein concentration in critically ill patients with suspected sepsis. Crit Care Med. 30:2002;271-275
17. Levi M. Sepsis and the coagulation system. Advances in Sepsis. 1:2000;16-22
18. Bernard G.R., Vincent J.L., Laterre P.F., et al. Efficacy and safety of recombinant activated protein C for severe sepsis. N Engl J Med. 344:2001;699-709
19. Creasey A.A., Reinhart K. Tissue factor pathway inhibitor activity in severe sepsis. Crit Care Med. 29:(Suppl):2001;S126-S129
20. Rodrigues J.C., Fein A. Diagnostic approach and clinical manifestations of severe sepsis. Fein A.M., Abraham A.M., Balk R.A., et al. Sepsis and multiorgan failure. 1997;269-276 Williams and Wilkins, Baltimore
21. Dhainaut J.F., Cariou A., Gest V. Cardiac dysfunction in sepsis. Fein A.M., Abraham A.M., Balk R.A., et al. Sepsis and multiorgan failure. 1997;209-219 Williams and Wilkins, Baltimore
22. Cook R., Cook D., Tilley J., Lee K., Marshall J. Multiple organ dysfunction: baseline and serial component scores. Crit Care Med. 29:2001;2046-2050
23. Piper R.D., Sibbald W.J. Multiple organ dysfunction syndrome. Fein A.M., Abraham A.M., Balk R.A., et al. Sepsis and multiorgan failure. 1997;189-208 Williams and Wilkins, Baltimore
24. Larosa S.P. Sepsis: menu of new approaches replaces one therapy for all. Cleve Clin J Med. 69:2002;65-72
25. Huber T.S., Gaines G.C., Welborn M.B., et al. Anticytokine therapies for acute inflammation and the systemic inflammatory response syndrome. Shock. 13:2000;425-434
26. Wheeler A.P., Bernard G.R. Treating patients with severe sepsis. N Engl J Med. 340:1999;207-214
27. Fitch S.J., Gossage J.R. Optimal management of septic shock. Postgrad Med. 111:(3):2002;53-66
28. Bone R.C. Managing sepsis: what treatments can we use today? J Crit Illn. 12:1997;15-24
29. Petri W.A. Antimicrobial agents. Hardman J.G., Limbird L.E., Gilman A.G. Goodman & Gilman's the pharmacological basis of therapeutics. 10th edition:2001;1189-1218 McGraw-Hill, New York
30. Reese R.E., Beets R.F., Gumustop B. Handbook of antibiotics. 2000;Lippincott Williams & Wilkins, Philadelphia
31. Conte E. Manual of antibiotics and infectious diseases. 9th edition:2002;Lippincott Williams & Wilkins, Philadelphia
32. Spapen H., Damas P., D'Orio V., et al. Consensus statement on the treatment of septic shock. Acta Clin Belg. 54-55:1999;256-262
33. Society of Critical Care Medicine. Press room: sepsis information. Available at: www.sccm.org. Accessed July 10, 2002